Muscle carnitine deficiency. Genetic heterogeneity.

Area of Science:

• Biochemistry
• Neurology
• Genetics

Background:

• Lipid storage myopathies are linked to reduced muscle carnitine levels.
• Distinguishing between muscle carnitine deficiency and systemic carnitine deficiency is crucial for diagnosis and treatment.
• Systemic carnitine deficiency results from impaired liver carnitine synthesis, affecting both serum and muscle carnitine.

Observation:

• A corticosteroid-responsive lipid storage myopathy, likely autosomal recessive, was studied.
• The patient presented with reduced muscle carnitine but normal serum carnitine.
• Carnitine therapy was ineffective in treating the myopathy and did not correct impaired fatty acid oxidation.

Findings:

• Carnitine transport into skeletal muscle was confirmed to be normal.
• The patient's condition did not improve with carnitine supplementation, unlike some previous cases.
• This case highlights that not all instances of muscle carnitine deficiency are identical.

Implications:

• The study suggests that 'muscle carnitine deficiency' is not a single entity.
• Further research is needed to understand the diverse mechanisms underlying lipid storage myopathies.
• Tailored therapeutic strategies may be required for different subtypes of carnitine-related myopathies.